Panomics (ex-Genospectra, Inc.), (Fremont, USA) creates novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. The company's products are targeted to research cellular pathways, to dissect molecular models of human disease, and to discover the next generation of medicines.